4.7 Review

Long Noncoding RNAs in the Regulation of Asthma: Current Research and Clinical Implications

Journal

FRONTIERS IN PHARMACOLOGY
Volume 11, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fphar.2020.532849

Keywords

asthma; long noncoding RNAs; airway inflammation; airway remodeling; glucocorticoid insensitivity

Funding

  1. National Natural Science Foundation of China [81774074, 81704154]
  2. Shanghai science and technology commission [17401930300, 18401971300]
  3. Young Elite Scientists Sponsorship Program by China Association for Science and Technology [2018QNRC001]
  4. Shanghai science and technology commission scientific research project [18401901800]

Ask authors/readers for more resources

Asthma is a chronic airway inflammatory disorder related to variable expiratory airflow limitation, leading to wheeze, shortness of breath, chest tightness, and cough. Its characteristic features include airway inflammation, airway remodeling and airway hyperresponsiveness. The pathogenesis of asthma remains extremely complicated and the detailed mechanisms are not clarified. Long noncoding RNAs (lncRNAs) have been reported to play a prominent role in asthma and function as modulators of various aspects in pathological progress of asthma. Here, we summarize recent advances of lncRNAs in asthma pathogenesis to guide future researches, clinical treatment and drug development, including their regulatory functions in the T helper (Th) 1/Th2 imbalance, Th17/T regulatory (Treg) imbalance, eosinophils dysfunction, macrophage polarization, airway smooth muscle cells proliferation, and glucocorticoid insensitivity.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available